HealthStream’s (HSTM) “Hold” Rating Reiterated at Canaccord Genuity Group

20 Dec 2025, 08:52 by Kim Johansen · The Markets Daily

Canaccord Genuity Group reaffirmed their hold rating on shares of HealthStream (NASDAQ:HSTM – Free Report) in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a $28.00 target price on the technology company’s stock.

Other analysts have also recently issued reports about the company. Wall Street Zen cut HealthStream from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of HealthStream in a report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, HealthStream currently has an average rating of “Hold” and a consensus target price of $28.00.

View Our Latest Stock Report on HSTM

HealthStream Price Performance

Shares of HSTM opened at $23.94 on Wednesday. The firm has a 50-day moving average of $25.08 and a 200-day moving average of $26.65. HealthStream has a one year low of $23.77 and a one year high of $34.24. The company has a market cap of $710.30 million, a PE ratio of 35.21, a price-to-earnings-growth ratio of 2.95 and a beta of 0.45.

HealthStream (NASDAQ:HSTM – Get Free Report) last issued its earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.03. HealthStream had a net margin of 6.93% and a return on equity of 5.82%. The company had revenue of $76.47 million for the quarter, compared to analysts’ expectations of $75.52 million. Analysts expect that HealthStream will post 0.63 earnings per share for the current year.

HealthStream Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were paid a dividend of $0.031 per share. The ex-dividend date was Monday, November 17th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is 17.65%.

HealthStream declared that its Board of Directors has authorized a share buyback program on Tuesday, November 11th that permits the company to buyback $10.00 million in outstanding shares. This buyback authorization permits the technology company to buy up to 1.3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity at HealthStream

In other HealthStream news, CTO Jeff Cunningham sold 2,100 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $24.09, for a total value of $50,589.00. Following the transaction, the chief technology officer directly owned 31,489 shares of the company’s stock, valued at $758,570.01. This trade represents a 6.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Tate Deborah Taylor sold 1,580 shares of the company’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $25.46, for a total value of $40,226.80. Following the sale, the director owned 23,127 shares of the company’s stock, valued at approximately $588,813.42. This represents a 6.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 5,680 shares of company stock worth $139,336 in the last ninety days. 20.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On HealthStream

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Copeland Capital Management LLC lifted its stake in HealthStream by 15.6% in the second quarter. Copeland Capital Management LLC now owns 882,950 shares of the technology company’s stock valued at $24,431,000 after buying an additional 119,260 shares during the period. Geode Capital Management LLC boosted its stake in HealthStream by 5.3% during the 2nd quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company’s stock valued at $21,202,000 after purchasing an additional 38,868 shares during the last quarter. Acadian Asset Management LLC grew its holdings in HealthStream by 5.1% during the second quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company’s stock worth $21,077,000 after buying an additional 37,004 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in HealthStream by 74.6% during the third quarter. JPMorgan Chase & Co. now owns 432,822 shares of the technology company’s stock worth $12,223,000 after purchasing an additional 184,917 shares during the last quarter. Finally, First Eagle Investment Management LLC boosted its stake in shares of HealthStream by 0.7% in the 3rd quarter. First Eagle Investment Management LLC now owns 409,398 shares of the technology company’s stock worth $11,561,000 after buying an additional 2,900 shares during the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.

About HealthStream

(Get Free Report)

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.